These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9166163)

  • 1. Immunohistochemistry of vascular changes in leuprolide acetate-treated leiomyomas.
    Mesia AF; Gahr D; Wild M; Mittal K; Demopoulos RI
    Am J Obstet Gynecol; 1997 May; 176(5):1026-9. PubMed ID: 9166163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leuprolide acetate depot for the treatment of uterine leiomyomas. Changes in bone density, uterine volume and uterine vascular resistive index.
    Rivlin ME; Patel RB; Hess LW; Hess DB; Meeks GR
    J Reprod Med; 1994 Sep; 39(9):663-6. PubMed ID: 7807474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
    Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
    J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.
    Sreenan JJ; Prayson RA; Biscotti CV; Thornton MH; Easley KA; Hart WR
    Am J Surg Pathol; 1996 Apr; 20(4):427-32. PubMed ID: 8604809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
    Mizutani T; Sugihara A; Nakamuro K; Terada N
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of a case of uterine leiomyoma showing massive lymphoid infiltration and localized vasculitis after LH-RH derivant treatment.
    Ohmori T; Wakamoto R; Lu LM; Okada K; Nose M
    Histopathology; 2002 Sep; 41(3):276-7. PubMed ID: 12207795
    [No Abstract]   [Full Text] [Related]  

  • 7. Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
    Lee MJ; Kazer RR
    Fertil Steril; 1992 Aug; 58(2):416-8. PubMed ID: 1633912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.
    Gutmann JN; Thornton KL; Diamond MP; Carcangiu ML
    Fertil Steril; 1994 Apr; 61(4):622-6. PubMed ID: 8150102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography.
    Aleem FA; Predanic M
    Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology of leiomyomata in patients treated with leuprolide acetate.
    Demopoulos RI; Jones KY; Mittal KR; Vamvakas EC
    Int J Gynecol Pathol; 1997 Apr; 16(2):131-7. PubMed ID: 9100066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study.
    Frijlingh M; De Milliano I; Hehenkamp WJK; Huirne JAF
    Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():186-192. PubMed ID: 31679806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment.
    Di Lieto A; De Rosa G; De Falco M; Iannotti F; Staibano S; Pollio F; Scaramellino M; Salvatore G
    Hum Pathol; 2002 Feb; 33(2):220-4. PubMed ID: 11957148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of leuprolide acetate on treatment of leiomyomata--clues to mechanisms of action.
    Demopoulos RI; Mesia AF
    Adv Anat Pathol; 1998 Mar; 5(2):129-36. PubMed ID: 9868519
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
    Cramer SF
    Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
    [No Abstract]   [Full Text] [Related]  

  • 16. Short term treatment with leuprolide acetate is a successful adjunct to surgical therapy of leiomyomas of the uterus.
    Coddington CC; Brzyski R; Hansen KA; Corley DR; McIntyre-Seltman K; Jones HW
    Surg Gynecol Obstet; 1992 Jul; 175(1):57-63. PubMed ID: 1621201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of insulin-like growth factor type I receptor and uterine volume changes in gonadotropin-releasing hormone analog-treated uterine leiomyomas.
    Di Lieto A; Iannotti F; De Falco M; Staibano S; Pollio F; Ciociola F; De Rosa G
    Am J Obstet Gynecol; 2003 Mar; 188(3):702-6. PubMed ID: 12634644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aborted leiomyosarcoma after treatment with leuprolide acetate.
    Mesia AF; Williams FS; Yan Z; Mittal K
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advanced endometriosis treatment with leuprolide acetate].
    Valdés P; Sierralta P
    Rev Chil Obstet Ginecol; 1993; 58(5):405-10. PubMed ID: 7991863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide acetate treatment and myoma arterial size.
    Rutgers JL; Spong CY; Sinow R; Heiner J
    Obstet Gynecol; 1995 Sep; 86(3):386-8. PubMed ID: 7651647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.